Patent Applications published on Oct 31, 2024 - page 3

#601
US20240358549A1
Human necessities

ADJUSTABLE SHUNTING SYSTEMS WITH ENERGY REDIRECTING ELEMENTS, AND ASSOCIATED METHODS AND DEVICES

#602
US20240358550A1
Human necessities

SURGICAL INSTRUMENT AND METHOD FOR GONIOTOMY PROCEDURE

#603
US20240358551A1
Human necessities

ROBOTIC ASSISTED PROCEDURES

#604
US20240358552A1
Human necessities

MOBILE WOUND COVER

#605
US20240358553A1
Human necessities

DYNAMICALLY ADJUSTABLE COMPRESSION GARMENT FOR A POST-OPERATIVE, POST-PARTUM, AND/OR OBESE PATIENT

#606
US20240358554A1
Human necessities

DISPOSABLE ABSORBENT ARTICLES HAVING CUFFS OF IMPROVED STRETCH LAMINATE STRUCTURE

#607
US20240358555A1
Human necessities

METHODS AND APPARATUSES FOR MAKING ELASTOMERIC LAMINATES WITH ELASTIC STRANDS PROVIDED WITH A SPIN FINISH

#608
US20240358556A1
Human necessities

METHODS AND APPARATUSES FOR MAKING ELASTOMERIC LAMINATES

#609
US20240358557A1
Human necessities

MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS

#610
US20240358558A1
Human necessities

DURABLE ABSORBENT PANT HAVING A VISUAL SIGNAL

#611
US20240358559A1
Human necessities

ABSORBENT ARTICLE WITH ANTI-LEAKAGE TRANSVERSAL BARRIER

#612
US20240358560A1
Human necessities

NATURAL FIBER-CONTAINING PACKAGES FOR ABSORBENT ARTICLES

#613
US20240358561A1
Human necessities

RECYCLABLE ABSORBENT ARTICLE PACKAGES

#614 ✅ Patent 12,232,941 granted on 2025-02-25
US20240358562A1
Human necessities

First aid kit alert system and a vehicle having the same

#615
US20240358563A1
Human necessities

HAMMOCK

#616
US20240358564A1
Human necessities

LIFT SYSTEM

#617
US20240358565A1
Human necessities

Aerospace-Based Healthcare Systems

#618
US20240358566A1
Human necessities

WHEELCHAIR DOCKING SYSTEM FOR A VEHICLE

#619
US20240358567A1
Human necessities

Foldable Seating Device

#620
US20240358568A1
Human necessities

MATTRESS FOR A PATIENT SUPPORT APPARATUS

#621
US20240358569A1
Human necessities

SUPPORT SURFACE OVERLAY WITH ACOUSTIC PATIENT DETECTION

#622
US20240358570A1
Human necessities

TRANSFER DEVICE

#623
US20240358571A1
Human necessities

SHEET ASSEMBLY FOR POSITIONING A PATIENT

#624
US20240358572A1
Human necessities

PREMATURE INFANT CARE SYSTEM

#625
US20240358573A1
Human necessities

SYSTEMS AND METHODS FOR SUPPORTING AND STABILIZING A PATIENT DURING HIP DISTRACTION

#626
US20240358574A1
Human necessities

PEG SUPPORT MEMBER

#627
US20240358575A1
Human necessities

IMPROVED SYSTEM FOR GASTROINTESTINAL HEALTH

#628
US20240358576A1
Human necessities

SafeNDry Crutch BOOTS

#629
US20240358577A1
Human necessities

MASSAGER FOR SHOULDERS AND NECK

#630
US20240358578A1
Human necessities

MASSAGE DEVICE COMPRISING IMPROVED INDEPENDENTLY OPERABLE LEG MASSAGE UNIT

#631
US20240358579A1
Human necessities

MASSAGE DEVICE AND MASSAGE UNIT

#632
US20240358580A1
Human necessities

SELF-BALANCING MASSAGE MANIPULATOR

#633
US20240358581A1
Human necessities

EXTERNAL COUNTER PULSATION DEVICE WITH EMR INTEGRATION FOR IDENTIFYING SUBJECTS

#634 ✅ Patent 12,268,654 granted on 2025-04-08
US20240358582A1
Human necessities

Negative pressure massager and massage method

#635
US20240358583A1
Human necessities

TRUNK AND LEG COMPRESSION GARMENT SYSTEMS

#636
US20240358584A1
Human necessities

EXTERNAL COUNTER PULSATION DEVICE WITH EMR INTEGRATION

#637 ✅ Patent 12,208,049 granted on 2025-01-28
US20240358585A1
Human necessities

Handheld roller

#638
US20240358586A1
Human necessities

TISSUE EXPANDER WITH SLIDABLE RIM

#639 ✅ Patent 12,178,774 granted on 2024-12-31
US20240358587A1
Human necessities

Reciprocating stimulation device

#640 ✅ Patent 12,201,577 granted on 2025-01-21
US20240358588A1
Human necessities

Reciprocating stimulation device

#641
US20240358589A1
Human necessities

EXTERNAL COUNTER PULSATION DEVICE WITH IMPROVED TIMING AND CONTROL

#642
US20240358590A1
Human necessities

ZERO MAGNETIC FIELD COIL FOR ACUPUNCTURE POINTS

#643
US20240358591A1
Human necessities

ENHANCED INSPECTION OF MEDICAMENTS AFTER LOADING OF BLISTER CARD PRESCRIPTIONS

#644
US20240358592A1
Human necessities

PHARMACEUTICAL CONTAINERS COMPRISING NECKS WITH NON-UNIFORM OUTER SURFACES AND METHODS REGARDING THE SAME

#645
US20240358593A1
Human necessities

DEVICES, SYSTEMS, AND METHODS FOR COMBINING AND/OR DELIVERING INJECTABLE MATERIALS

#646
US20240358594A1
Human necessities

DEVICES, SYSTEMS, AND METHODS FOR COMBINING AND/OR DELIVERING INJECTABLE MATERIALS

#647
US20240358595A1
Human necessities

PILL DISPENSER

#648
US20240358596A1
Human necessities

SYSTEMS AND METHODS FOR MANAGING MEDICINE USAGE

#649
US20240358597A1
Human necessities

LIVE MONITORING PILL DISPENSING DEVICE

#650 ✅ Patent 12,144,783 granted on 2024-11-19
US20240358598A1
Human necessities

Dose tracking device

#651
US20240358599A1
Human necessities

CLOUD-BASED MEDICATION MANAGEMENT SYSTEM AND METHOD

#652
US20240358600A1
Human necessities

A Gastrojejunostomy Tube Enabling Bedside Exchange Without Radiation, Sedation, or Procedure Room Time

#653
US20240358601A1
Human necessities

ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME

#654
US20240358602A1
Human necessities

DEVICES AND METHODS FOR A HYPER REALISTIC BREAST SHAPED SOOTHER

#655
US20240358603A1
Human necessities

One-Part Dental Adhesive Composition for Fixing Dental Composite Materials

#656
US20240358604A1
Human necessities

Light Emitting Dental Compositions and Methods of Using the Same

#657
US20240358605A1
Human necessities

PERSONAL CARE COMPOSITIONS

#658
US20240358606A1
Human necessities

ACTIVE TREATMENT FORMULATION AND SKIN TREATMENT ARTICLE INCLUDING ACTIVE TREATMENT FORMULATION APPLIED TO WATER-DISPERSIBLE AND/OR WATER-SOLUBLE CORE SUBSTRATE

#659
US20240358607A1
Human necessities

MANUFACTURING METHOD FOR SOLID PERSONAL CARE PRODUCT

#660
US20240358608A1
Human necessities

POWDER FILLING TECHNOLOGY FOR AEROSOL CANISTERS

#661
US20240358609A1
Human necessities

STRUCTURALLY DIVERSE, STABLE, AND RADIATION-PROTECTIVE PARTICLE MATRIX SUNSCREEN AND COSMETIC COMPOSITIONS AND RELATED METHODS

#662
US20240358610A1
Human necessities

ANHYDROUS TOPICAL DELIVERY SYSTEM FOR LIPID, AQUEOUS, AND ALCOHOL SOLUBILIZED ACTIVES

#663
US20240358611A1
Human necessities

COMPOSITIONS

#664
US20240358612A1
Human necessities

METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POST-TREATMENT AGENT

#665
US20240358613A1
Human necessities

USE OF SACCHARIDES FOR CRYOPROTECTION AND RELATED TECHNOLOGY

#666
US20240358614A1
Human necessities

USE OF A RHAMNOLIPID IN A SURFACTANT SYSTEM

#667
US20240358615A1
Human necessities

COMPOSITION FOR CARING FOR KERATIN MATERIALS

#668
US20240358616A1
Human necessities

Skincare Composition

#669
US20240358617A1
Human necessities

Heat Stable and/or Heat Activated Biopolymers

#670
US20240358618A1
Human necessities

NAIL POLISH TOPCOAT COMPOSITION

#671
US20240358619A1
Human necessities

NAIL POLISH COLOR COAT COMPOSITION

#672
US20240358620A1
Human necessities

COSMETIC COMPOSITION WITH ENHANCED PHOTOPROTECTION PROPERTIES

#673
US20240358621A1
Human necessities

PERSONAL CARE COMPOSITION

#674
US20240358622A1
Human necessities

CARE AND/OR MAKEUP COMPOSITION COMPRISING A SILICONE ELASTOMER CONTAINING CARBOXYLIC ACID FUNCTIONS AND A COPOLYMER BASED ON SILICONE RESIN AND ON SILICONE OF DIMETHICONOL TYPE

#675
US20240358623A1
Human necessities

LONG-WEAR COMPOSITIONS CONTAINING SILICONE ACRYLATE COPOLYMER AND GLYCEROLATED SILICONE RESIN

#676
US20240358624A1
Human necessities

APPLICATION TYPE BODY-CORRECTING-FILM FORMING AGENT

#677
US20240358625A1
Human necessities

STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS

#678 ✅ Patent 12,161,747 granted on 2024-12-10
US20240358626A1
Human necessities

Gum and tooth treatment method with rinsing

#679
US20240358627A1
Human necessities

Anti-Obesity Agent, Anti-Dementia Agent, Deodorant, Anti-Aging Agent, Anti-Glycation Agent, Anti-Type I Allergy Agent, Hypotensive Agent, Flavor Improving Agent, Muscle Enhancing Agent, and Bone Metabolism Improving Agent

#680
US20240358628A1
Human necessities

CYANOBACTERIAL POLYSACCHARIDE COMPOSITIONS

#681
US20240358629A1
Human necessities

SELF-PROPELLED PHARMACEUTICAL DELIVERY CAPSULES

#682
US20240358630A1
Human necessities

MICROMOTORS AND NANOMOTORS FOR GASTROINTESTINAL DIAGNOSIS AND TREATMENT APPLICATIONS

#683
US20240358631A1
Human necessities

TOPICAL FORMULATIONS

#684
US20240358632A1
Human necessities

READY TO USE COMPOSITIONS OF CETRORELIX ACETATE

#685
US20240358633A1
Human necessities

METHOD OF PROVIDING BIRTH CONTROL

#686
US20240358634A1
Human necessities

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

#687
US20240358635A1
Human necessities

LONG CYCLE-LIFE WOUND LITHIUM-ION BATTERY CELLS HAVING METALLIZED FILM CURRENT COLLECTORS

#688
US20240358636A1
Human necessities

MEDICAL LIQUID COMPOSITION FOR AERIAL ADMINISTRATION

#689
US20240358637A1
Human necessities

SPRAY APPLICATION OF WATER SOLUBLE ACTIVES TO DRINKING VESSELS AND OTHER OBJECTS

#690
US20240358638A1
Human necessities

FOAM COMPOSITIONS FOR TREATING CLOSTRIDIOIDES DIFFICILE INFECTIONS

#691
US20240358639A1
Human necessities

NANOPARTICLES FOR CANCER TREATMENT

#692
US20240358640A1
Human necessities

ULTRASOUND-SENSITIVE PEPTIDE PARTICLES FOR SPATIALLY RESOLVED MOLECULE DELIVERY

#693
US20240358641A1
Human necessities

PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE

#694
US20240358642A1
Human necessities

COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN

#695
US20240358643A1
Human necessities

AN AMORPHOUS SOLID DISPERSION OF A QUINOLONE COMPOUND AND PROCESS FOR THE PREPARATION THEREOF

#696
US20240358644A1
Human necessities

ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION

#697
US20240358645A1
Human necessities

NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF

#698
US20240358646A1
Human necessities

HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING

#699
US20240358647A1
Human necessities

Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same

#700
US20240358648A1
Human necessities

MULTIFUNCTIONAL (METH)ACRYLATE POLYSACCHARIDE MICROCAPSULES

#701
US20240358649A1
Human necessities

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

#702
US20240358650A1
Human necessities

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

#703
US20240358651A1
Human necessities

ORAL NANOPARTICLES FOR BIOACTIVE COMPOUND, AND METHOD OF PREPARING SAME

#704
US20240358652A1
Human necessities

LIPID NANOPARTICLE FORMULATIONS

#705
US20240358653A1
Human necessities

NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND

#706
US20240358654A1
Human necessities

PREPARATION METHOD AND USE OF POROUS STARCH FOR ENCAPSULATING PROBIOTIC

#707
US20240358655A1
Human necessities

Transdermal Systems having low dose estrogen and methods of making and use

#708
US20240358656A1
Human necessities

IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER AND METHODS OF PREPARING THE SAME

#709
US20240358657A1
Human necessities

erecting/erection ,treat impotence.

#710
US20240358658A1
Human necessities

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

#711
US20240358659A1
Human necessities

Uses of Propranolol for Managing Viral Infections

#712
US20240358660A1
Human necessities

COMPOSITION FOR THE TREATMENT OF REFRACTORY PAINFUL INTERVERTEBRAL DISC RELATED DISORDERS AND METHOD FOR DELIVERY THEREOF TO TREAT THERETO

#713
US20240358661A1
Human necessities

DOSAGE FORMS OF MIRDAMETINIB

#714
US20240358662A1
Human necessities

COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY

#715
US20240358663A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

#716
US20240358664A1
Human necessities

VIGABATRIN LIQUID PHARMACEUTICAL COMPOSITION

#717
US20240358665A1
Human necessities

SMALL MOLECULE MELPHALAN HYDROGEL AND METHOD FOR PREPARING THE SAME

#718 ✅ Patent 12,186,298 granted on 2025-01-07
US20240358666A1
Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#719 ✅ Patent 12,263,150 granted on 2025-04-01
US20240358667A1
Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#720
US20240358668A1
Human necessities

METHODS AND COMPISITIONS FOR AMELIORATING BIOMARKERS ASSOCIATED WITH CARDIOVASCUALR RISK USING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE

#721
US20240358669A1
Human necessities

METHODS FOR TREATING PANCREATIC CANCER

#722
US20240358670A1
Human necessities

DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS

#723
US20240358671A1
Human necessities

COMPOSITIONS AND METHODS TO TREAT SKIN DISORDERS

#724
US20240358672A1
Human necessities

APPLICATION OF GENISTEIN AND ITS PHOSPHATE ESTER DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#725
US20240358673A1
Human necessities

SHORT CHAIN FATTY ACIDS & GALLATES COMPOSITIONS

#726
US20240358674A1
Human necessities

COMPOSITIONS AND DOSAGE FORMS FOR ORAL DELIVERY

#727
US20240358675A1
Human necessities

MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

#728
US20240358676A1
Human necessities

COMPOSITIONS AND METHODS FOR PAIN RELIEF

#729
US20240358677A1
Human necessities

LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER

#730
US20240358678A1
Human necessities

METHODS AND COMPOSITIONS FOR ENHANCING CHEMOTHERAPEUTIC DRUG UPTAKE INTO BRAIN TUMORS

#731
US20240358679A1
Human necessities

PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES

#732
US20240358680A1
Human necessities

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO

#733
US20240358681A1
Human necessities

METHODS OF USE OF PPAR AGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF

#734
US20240358682A1
Human necessities

USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

#735
US20240358683A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE COMPRISING COMPOUND INDUCING EXPRESSION OF ANTI-AGING GENE KLOTHO

#736
US20240358684A1
Human necessities

METHOD FOR ENHANCING INNATE IMMUNE RESPONSE

#737
US20240358685A1
Human necessities

ACYL BENZO[D]THIAZOL-2-AMINE AND THEIR METHODS OF USE

#738
US20240358686A1
Human necessities

TIZANIDINE LIQUID PREPARATION AND USE THEREOF

#739
US20240358687A1
Human necessities

USE OF NOX INHIBITORS FOR TREATMENT OF CANCER

#740
US20240358688A1
Human necessities

SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS

#741
US20240358689A1
Human necessities

Modulators Of The Beta-3 Adrenergic Receptor Useful For The Treatment Or Prevention Of Renal Cystic Disease and Cardiorenal Syndrome

#742
US20240358690A1
Human necessities

METHODS OF TREATING IDIOPATHIC PULMONARY FIBROSIS WITH DEUPIRFENIDONE

#743
US20240358691A1
Human necessities

PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE

#744
US20240358692A1
Human necessities

TREATMENT OF SCLERODERMA

#745
US20240358693A1
Human necessities

METHODS OF TREATING PAIN

#746
US20240358694A1
Human necessities

SUSTAINED-RELEASE INJECTION PREPARATION CONTAINING DONEPEZIL AND PREPARATION METHOD THEREFOR

#747
US20240358695A1
Human necessities

Pharmaceutical Compositions of Rimegepant

#748
US20240358696A1
Human necessities

METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING BUPROPION

#749
US20240358697A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME

#750
US20240358698A1
Human necessities

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#751
US20240358699A1
Human necessities

METHOD OF REDUCING PULMONARY EXACERBATIONS IN RESPIRATORY DISEASE PATIENTS

#752 ✅ Patent 12,144,809 granted on 2024-11-19
US20240358700A1
Human necessities

Treatment of prostate cancer

#753
US20240358701A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF

#754
US20240358702A1
Human necessities

CYCLIC UREA KRAS INHIBITORS

#755
US20240358703A1
Human necessities

METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES AND EWING'S SARCOMA

#756
US20240358704A1
Human necessities

COMBINED ADMINISTRATION

#757
US20240358705A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

#758
US20240358706A1
Human necessities

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

#759
US20240358707A1
Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE

#760
US20240358708A1
Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING LYMPHOID MALIGNANCY

#761
US20240358709A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

#762
US20240358710A1
Human necessities

METHODS, COMPOSITIONS AND DEVICES FOR TREATING CANCER WITH ILLUDOFULVENES

#763
US20240358711A1
Human necessities

COMPOUNDS FOR NEUTROPHIL ROS INHIBITION

#764
US20240358712A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING SEXUAL SENSORY DISORDERS

#765
US20240358713A1
Human necessities

PHARMCAEUTICAL COMPOSITION CONTAINING BENZOXAZEPINE DERIVATIVES, AND A METHOD FOR TREATING CANCER

#766
US20240358714A1
Human necessities

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT

#767
US20240358715A1
Human necessities

METHODS OF REDUCING MAMMOGRAPHIC BREAST DENSITY AND/OR BREAST CANCER RISK

#768
US20240358716A1
Human necessities

HALOBETASOL PROPIONATE-LIDOCAINE FORMULATIONS

#769
US20240358717A1
Human necessities

APPLICATION OF B-ECDYSTERONE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND HYPERURICEMIC KIDNEY INJURY

#770
US20240358718A1
Human necessities

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS

#771
US20240358719A1
Human necessities

Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation

#772
US20240358720A1
Human necessities

Dosing Regimen for a TEAD inhibitor

#773
US20240358721A1
Human necessities

GASDERMIN-D INHIBITORS AND USES THEREOF FOR TREATING PULMONARY VASO-OCCLUSION

#774
US20240358722A1
Human necessities

METHODS OF ADMINISTERING FEDRATINIB

#775 ✅ Patent 12,295,962 granted on 2025-05-13
US20240358723A1
Human necessities

Polymorphic compounds and uses thereof

#776
US20240358724A1
Human necessities

BEVERAGE TABLET AND METHOD OF CUSTOMIZING AN AQUEOUS BEVERAGE USING THE SAME

#777
US20240358725A1
Human necessities

INHALANT CANNABIDIOL (CBD) IN THE TREATMENT OF GLIOBLASTOMA

#778
US20240358726A1
Human necessities

SPECIFIC THERAPEUTIC MEDICAL MARIJUANA DOSES FOR STRESS AND PAIN

#779
US20240358727A1
Human necessities

MICROSCALE THERMOPHORESIS TO EVALUATE CHANNEL LIPID INTERACTIONS AND METHODS OF TREATING NAV CHANNELS RELATED DISEASES

#780
US20240358728A1
Human necessities

BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS

#781
US20240358729A1
Human necessities

COMPOSITION CONTAINING 2'-FL FOR AMELIORATING, PREVENTING OR TREATING DISEASES CAUSED BY REDUCTION OF DOPAMINE

#782
US20240358730A1
Human necessities

PREBIOTIC COMPOSITIONS AND METHODS OF PRODUCTION THEREOF

#783
US20240358731A1
Human necessities

SUMO PATHWAY AS AN OXYGEN SENSOR RELEVANT TO THE PATHOPHYSIOLOGY OF PULMONARY ARTERY HYPERTENSION AND CARDIAC ARRHYTHMIA

#784
US20240358732A1
Human necessities

Use of Rutin and Rapamycin in the Preparation of Synergistic Chemotherapy Drugs for Tumor Inhibition

#785
US20240358733A1
Human necessities

APPLICATION OF TYPHANEOSIDE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND/OR KIDNEY INJURY

#786
US20240358734A1
Human necessities

DISCOVERY OF NOVEL TRPV1 CHANNEL BLOCKERS BY HIGH-THROUGHPUT SCREENING OF MARINE NATURAL PRODUCTS

#787
US20240358735A1
Human necessities

THERAPEUTIC COMPOSITIONS AND RELATED METHODS

#788
US20240358736A1
Human necessities

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING

#789
US20240358737A1
Human necessities

NUCLEIC ACIDS FOR CELL RECOGNITION AND INTEGRATION

#790
US20240358738A1
Human necessities

EXTRAHEPATIC DELIVERY

#791
US20240358739A1
Human necessities

COMPOSITION AND METHOD TO TREAT CACHEXIA

#792
US20240358740A1
Human necessities

FOLIC COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC NEUROPATHIES

#793
US20240358741A1
Human necessities

MUCOADHESlVE POLYMERS FOR NASAL DRUG DELIVERY

#794
US20240358742A1
Human necessities

A PHARMACEUTICAL COMPOSITION COMPRISING POLOXAMER 188 FOR IMPROVING THE FILTERING FUNCTION OF KIDNEYS

#795
US20240358743A1
Human necessities

COSMETIC/DERMATOLOGICAL COMPOSITION

#796
US20240358744A1
Human necessities

WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF

#797
US20240358745A1
Human necessities

COMPOSITIONS AND METHODS OF DISSOLVING BIOFILM TO PROMOTE WOUND HEALING

#798
US20240358746A1
Human necessities

METHOD OF OBTAINING STABLE SUSPENSIONS OF HETEROCRYSTALS OF TITANIUM DIOXIDE OR PARTICLES OF SILICON DIOXIDE AND STABLE SUSPENSIONS OBTAINED BY THIS METHOD FOR INITIATION OF ACTIVE FORM OF OXYGEN IN BODY AT USE IN MEDICAL FORMS

#799
US20240358747A1
Human necessities

SOME GEL FORMULATIONS THAT PROVIDE WOUND HEALING AND THE SYNTHESIS OF DYSPROSIUM ERBIUM BORATE TRIHYDRATE (Dy0.5Er0.5BO3.3H2O) COMPOUND USED IN THESE FORMULATIONS

#800
US20240358748A1
Human necessities

AMORPHOUS DISPERSION OF FERRIC MALTOL AND THE PREPARATION PROCESS THEREOF

#801
US20240358749A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET

#802 ✅ Patent 12,133,864 granted on 2024-11-05
US20240358750A1
Human necessities

Method for treating cancer cells with a Cu/Ag particle composition

#803
US20240358751A1
Human necessities

IPSC-DERIVED IMMUNE CELLS IN PROPHYLAXIS AND TREATMENT OF AGE-ASSOCIATED AND NEURODEGENERATIVE DISEASES

#804
US20240358752A1
Human necessities

COMPOSITION FOR TREATING DAMAGED EPITHELIAL SURFACES AND METHOD OF PRODUCING SAME

#805
US20240358753A1
Human necessities

METHODS FOR DEVELOPING CD3+CD8+ CELLS AGAINST MULTIPLE VIRAL EPITOPES FOR TREATMENT OF VIRAL INFECTIONS INCLUDING VARIANTS EVOLVING TO ESCAPE PREVIOUS IMMUNITY

#806
US20240358754A1
Human necessities

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

#807 ✅ Patent 12,290,530 granted on 2025-05-06
US20240358755A1
Human necessities

Peptides displayed by HLA for use in immunotherapy against different types of cancers

#808 ✅ Patent 12,318,407 granted on 2025-06-03
US20240358756A1
Human necessities

Peptides displayed by HLA for use in immunotherapy against different types of cancers

#809
US20240358757A1
Human necessities

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#810
US20240358758A1
Human necessities

METHODS FOR TREATMENT OF AUTOIMMUNE DISEASES

#811
US20240358759A1
Human necessities

COMBINATION CANCER THERAPY WITH MEMORY NK CELLS AND ANTI-CANCER BISPECIFIC MOLECULES

#812
US20240358760A1
Human necessities

Primary T-Cell Expansion

#813
US20240358761A1
Human necessities

GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY

#814
US20240358762A1
Human necessities

MOLECULES THAT BIND TO PROTOGENIN (PRTG) POLYPEPTIDES

#815
US20240358763A1
Human necessities

SUPPLEMENT FOR HUMAN MILK FROM ALLERGIC WOMEN

#816
US20240358764A1
Human necessities

NEURONAL REGENERATION PROMOTING CELLS (NRPCs) AND TREATING DAMAGED NERVE CELLS

#817
US20240358765A1
Human necessities

COMPOSITION FOR TREATING LIVER DYSFUNCTION

#818
US20240358766A1
Human necessities

ALLOGENEIC CULTURED KERATINOCYTE PRODUCTS

#819
US20240358767A1
Human necessities

STEM CELL DIFFERENTIATION AND CHEMICAL COMPOUNDS

#820
US20240358768A1
Human necessities

Methods and Systems for Improved Therapies of Genetic Diseases Using Photo-Activated Allogenic Stem Cells

#821
US20240358769A1
Human necessities

Compositions and Methods for Treating Inflammation Associated with IL-6

#822
US20240358770A1
Human necessities

METHODS OF TREATING PODODERMATITIS

#823
US20240358771A1
Human necessities

PRODUCT DERIVED FROM RHODOCOCCUS RUBER, AND PHARMACEUTICAL USE THEREOF

#824
US20240358772A1
Human necessities

Mycobacteria From Single Colony Type for Vaccine and Other Immunotherapy

#825
US20240358773A1
Human necessities

Parabacteroides Goldsteinii to Treat or Prevent Inflammatory and AutoImmune Diseases

#826
US20240358774A1
Human necessities

USE OF MICROBIOME IN THE FIELD OF MICROBIALS AND THERAPEUTICS

#827
US20240358775A1
Human necessities

METHOD OF ALTERING MICROBIOMES TO PRODUCE BENEFICIAL EFFECTS

#828
US20240358776A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

#829
US20240358777A1
Human necessities

COMPOSITIONS COMPRISING BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING ULCERATIVE COLITIS

#830
US20240358778A1
Human necessities

METHOD OF MODULATING THE MICROBIOME

#831
US20240358779A1
Human necessities

EXTRACELLULAR VESICLES DERIVED FROM LACTOBACILLUS BACTERIA, AND USE THEREOF

#832
US20240358780A1
Human necessities

ARMED CHIMERIC ONCOLYTIC VIRUSES

#833
US20240358781A1
Human necessities

ALTERED VIRUS

#834
US20240358782A1
Human necessities

Regulatory Composition of the Neuro-Immune-Endocrine and Cortisol Reducing System of the Human Being

#835
US20240358783A1
Human necessities

METHOD AND SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF A PSYCHEDELIC AGENT

#836
US20240358784A1
Human necessities

DECARBOXYLATED CANNABIS COMPOSITIONS AND METHODS OF MAKING THE SAME

#837
US20240358785A1
Human necessities

DIETARY AND FOOD SUPPLEMENT COMPOSITION FOR WEIGHT LOSS AND APPETITE REDUCTION AND USE THEREOF

#838
US20240358786A1
Human necessities

METHODS FOR MAKING BOTANICAL EXTRACT COMPOSITION

#839
US20240358787A1
Human necessities

USE OF MANGOSTEEN FRUIT SHELL EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR PROMOTING WOUND HEALING IN DIABETES

#840
US20240358788A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING RADIATION DERMATITIS

#841 ✅ Patent 12,285,458 granted on 2025-04-29
US20240358789A1
Human necessities

Compositions and methods for alleviating adverse effects from responsible alcohol consumption

#842
US20240358790A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY

#843
US20240358791A1
Human necessities

PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME

#844
US20240358792A1
Human necessities

LIQUID DALBAVANCIN COMPOSITIONS

#845
US20240358793A1
Human necessities

METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS

#846
US20240358794A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF DISORDERS AFFECTING THE CENTRAL NERVOUS SYSTEM

#847
US20240358795A1
Human necessities

FGF10 FOR THE TREATMENT OF HEART DISEASES

#848
US20240358796A1
Human necessities

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

#849
US20240358797A1
Human necessities

ONCOSELECTIVE CANCER THERAPY

#850
US20240358798A1
Human necessities

TREATMENT FOR SARS-COV-2 AND OTHER CORONAVIRUSES

#851
US20240358799A1
Human necessities

METHODS AND COMPOSITIONS FOR REPRODUCTIVE MANAGEMENT OF SHEEP AND GOATS

#852
US20240358800A1
Human necessities

FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

#853
US20240358801A1
Human necessities

MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A

#854
US20240358802A1
Human necessities

Blood Plasma Fractions for Use in Muscle Regeneration

#855
US20240358803A1
Human necessities

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER

#856
US20240358804A1
Human necessities

VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES

#857
US20240358805A1
Human necessities

METHODS AND MATERIALS TO TREAT NEURODEGENERATIVE DISEASE

#858
US20240358806A1
Human necessities

METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES

#859
US20240358807A1
Human necessities

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

#860
US20240358808A1
Human necessities

VACCINE FOR SARS-COV-2

#861
US20240358809A1
Human necessities

CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF

#862
US20240358810A1
Human necessities

Shigella Vaccine

#863
US20240358811A1
Human necessities

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE

#864
US20240358812A1
Human necessities

HUMAN METAPNEUMOVIRUS COMBINATION VACCINE

#865 ✅ Patent 12,303,559 granted on 2025-05-20
US20240358813A1
Human necessities

Multivalent Epstein-Barr virus-like particles and uses thereof

#866 ✅ Patent 12,318,441 granted on 2025-06-03
US20240358814A1
Human necessities

Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases

#867
US20240358815A1
Human necessities

METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE

#868
US20240358816A1
Human necessities

FMDV VIRUS-LIKE PARTICLE WITH STABILIZING MUTATION

#869
US20240358817A1
Human necessities

STRUCTURES OF LANGYA VIRUS FUSION PROTEIN ECTODOMAIN AND IMMUNOGENIC COMPOSITIONS DERIVED THEREFROM

#870
US20240358818A1
Human necessities

ANTIBODY-INDUCING POLYPEPTIDE AND VACCINE

#871
US20240358819A1
Human necessities

PAN-HUMAN CORONAVIRUS DOMAIN VACCINES

#872
US20240358820A1
Human necessities

PROTOPARVOVIRUS COMPOSITIONS COMPRISING A PROTOPARVOVIRUS VARIANT VP1 CAPSID POLYPEPTIDE AND RELATED METHODS

#873
US20240358821A1
Human necessities

P7 Containing Nucleoside-modified mRNA-lipid Nanoparticle Lineage Vaccine for Hepatitis C Virus

#874
US20240358822A1
Human necessities

ALLERGY TREATMENT

#875
US20240358823A1
Human necessities

CONJUGATED VACCINE CARRIER PROTEINS

#876
US20240358824A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

#877
US20240358825A1
Human necessities

Novel Adjuvant Compositions

#878
US20240358826A1
Human necessities

INTERLEUKIN-1 ALPHA CHIMERIC PROTEIN

#879
US20240358827A1
Human necessities

STABLE LIQUID FORMULA

#880
US20240358828A1
Human necessities

ENGINEERED NK CELLS, METHODS OF THEIR PRODUCTION AND USES THEREOF

#881
US20240358829A1
Human necessities

Lymphocyte Population and Methods for Producing Same

#882
US20240358830A1
Human necessities

ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES

#883
US20240358831A1
Human necessities

SELECTION OF IMMUNE CELLS USING PEPTIDE MHC COMPLEXES GENERATED BY CONDITIONAL LIGAND EXCHANGE

#884
US20240358832A1
Human necessities

T CELL RECEPTOR, AND PREPARATION METHOD AND USE THEREOF

#885
US20240358833A1
Human necessities

HLA-A2-SPECIFIC REGULATORY T CELLS

#886
US20240358834A1
Human necessities

NOVEL CD19-TARGETING POLYPEPTIDES AND CD19-DIRECTED IMMUNOTHERAPIES

#887
US20240358835A1
Human necessities

TUMOR INFILTRATING LYMPHOCYTES WITH INCREASED METABOLIC ACTIVITY

#888
US20240358836A1
Human necessities

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

#889
US20240358837A1
Human necessities

Amorphous Photosensitizing Particles, Methods For The Preparation Thereof, And Methods For The Use Thereof

#890
US20240358838A1
Human necessities

LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES

#891
US20240358839A1
Human necessities

PROGESTERONE FORMULATIONS HAVING A DESIRABLE PK PROFILE

#892
US20240358840A1
Human necessities

TOPICAL FORMULATIONS AND USES THEREOF

#893
US20240358841A1
Human necessities

NANOMATERIALS COMPRISING TETRAVALENT LIPID COMPOUNDS

#894
US20240358842A1
Human necessities

PROTEIN STABILIZING COMPOUNDS CONTAINING USP7 LIGANDS

#895
US20240358843A1
Human necessities

LIGAND-DRUG CONJUGATE AND USE THEREOF

#896
US20240358844A1
Human necessities

THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS

#897
US20240358845A1
Human necessities

COMPOSITIONS AND METHODS FOR INTRACELLULAR THERAPEUTICS

#898
US20240358846A1
Human necessities

Nanoparticles and Peptides for the Delivery of Cargos to Muscle Cells

#899
US20240358847A1
Human necessities

TROP2 BINDERS AND CONJUGATES THEREOF

#900
US20240358848A1
Human necessities

ANTITUMOR COMPOUND AND USE THEREOF